1 A newly discovered human pneumovirus isolated from young children with respiratory tract disease

2 Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus

3 Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication

4 Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse

5 Respiratory virus infection of peripheral blood monocytes: correlation with ageing of cells and interferon production in vitro

6 RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA

7 Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant

8 Characterization of oligosaccharide structures on a chimeric respiratory syncytial virus protein expressed in insect cell line Sf9

9 Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome

10 Inhibition of respiratory syncytial virus replication by antisense oligodeoxyribonucleotides

11 Surveillance for acute viral hepatitis - United States, 2007

12 neurite óptica bilateral após infecção viral por dengue: relato de casos bilateral optic neuritis after dengue viral infection: case report

13 the humoral immune response to hcv: understanding is key to vaccine development

14 H5N1 infection of the respiratory tract and beyond: a molecular pathology study

15 Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus

16 COVID-19: combining antiviral and anti-inflammatory treatments

17 Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons

18 Transcription activation by the adenovirus E1a protein

19 Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial

20 Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China

21 Studies on leukocyte cultures in measles. II. Detection of measles virus antigen in human leucocytes by immunofluorescence

22 Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice

23 Resistance analysis in patients with genotype 1-6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies

24 Combined inhibition of influenza virus reproduction in cell culture using interferon and amantadine

25 Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

26 Enzyme immunoassays for viral diseases

27 Rhinoviruses infect the lower airways

28 Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

29 Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice

30 Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine.

31 Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B

32 Higher baseline viral diversity correlates with lower HBsAg decline following PEGylated interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B

33 Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs

34 Influence of host resistance on viral adaptation: hepatitis C virus as a case study

35 Influenza A Viral Infection with Septic Shock in Pregnancy

36 Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B

37 Higher baseline viral diversity correlates with lower HBsAg decline following PEGylated interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B

38 Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs

39 A Case of Terson-Like Syndrome in a Patient with Viral Meningoencephalitis

40 Epidemiologic Trends of Viral Skin Infections in Egypt: A Cross-Sectional Hospital-Based Study

41 Influence of host resistance on viral adaptation: hepatitis C virus as a case study

42 Excellence in Viral Hepatitis Elimination - Lessons from Georgia.

43 The Utilization of Cell-Penetrating Peptides in the Intracellular Delivery of Viral Nanoparticles.

44 The Utilization of Cell-Penetrating Peptides in the Intracellular Delivery of Viral Nanoparticles

45 Innovative strategies for the elimination of viral hepatitis at a national level: a country case series.

46 Optimizing viral load testing access for the last mile: Geospatial cost model for point of care instrument placement.

47 What is the optimal timing of antiviral treatment in pregnant hepatitis B carrier with extremely high viral load?

48 A point mutation to the long terminal repeat of bovine leukemia virus related to viral productivity and transmissibility.

49 Clinical significance of post-treatment viral load of cytomegalovirus in patients with hematologic malignancies.

50 Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.

51 Evaluation of the HBV Genotype, Viral Load and Antivirus Drug Resistance Mutation in Tay Ninh Hospital, Vietnam by Real-Time PCR

52 Impact of coxsackievirus-B4E2 combined with a single low dose of streptozotocin on pancreas of outbred mice: investigation of viral load, pathology and inflammation

53 Increased Plasma Levels of the TH2 chemokine CCL18 associated with low CD4+ T cell counts in HIV-1-infected Patients with a Suppressed Viral Load

54 Infant follow-up postdelivery from a hepatitis C viral load positive mother

55 Tualang honey ameliorates viral load, CD4 counts and improves quality of life in asymptomatic human immunodeficiency virus infected patients

56 Feasibility of using dried blood spots for HIV viral load testing among HIV-infected individuals in Thailand using QIAGEN QIAsymphony-artus HIV-1 platform

57 Roles of Epstein–Barr virus viral load monitoring in the prediction of posttransplant lymphoproliferative disorder in pediatric liver transplantation

58 A methodology for deriving the sensitivity of pooled testing, based on viral load progression and pooling dilution

59 Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: Predicted effect of using a single viral load to define efavirenz-based first-line failure

60 Impact of HIV-Status Disclosure on HIV Viral Load in Pregnant and Postpartum Women on Antiretroviral Therapy

61 Evaluating the effectiveness of the HIV adolescent package of care (APOC) training on viral load suppression in Kenya

62 The new Xpert HCV viral load real-time PCR assay accurately quantifies hepatitis C virus RNA in serum and whole-blood specimens

63 Inoculation of specific pathogen-free chickens with an infectious bursal disease virus of the ITA genotype (G6) leads to a high and persistent viral load in lymphoid tissues and to a delayed antiviral response

64 HIV serostatus, viral load, and midtrimester cervical length in a Zambian prenatal cohort

65 HIV low viral load persistence under treatment: Insights from a model of cell-to-cell viral transmission

66 HIV stigma and viral load among African-American women receiving treatment for HIV

67 Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults with Incident HIV-1 Infection

68 Letter to the editor: Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infections

69 Analytical treatment interruption in chronic HIV-1 infection: Time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study)

70 Felis catus papillomavirus type 2 virus-like particle vaccine is safe and immunogenic but does not reduce FcaPV-2 viral loads in adult cats

71 Brief Report: Durability of the Effect of Financial Incentives on HIV Viral Load Suppression and Continuity in Care: HPTN 065 Study

72 High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation

73 Tenofovir and telbivudine combination therapy rapidly decreases viral loads in immune-tolerant chronic hepatitis B patients awaiting assisted reproduction: An open-label, randomized, controlled study

74 Inhibition of HIV-1 envelope-dependent membrane fusion by serum antilymphocyte autoantibodies is associated with low plasma viral load

75 A modified HIV continuum of care: A six-year evaluation of a viral load cascade at a hospital-based clinic in Kingston, Jamaica

76 Honeybee (Apis mellifera) Venom Reinforces Viral Clearance during the Early Stage of Infection with Porcine Reproductive and Respiratory Syndrome Virus through the Up-Regulation of Th1-Specific Immune Responses

77 Influence of maintained hemodialysis on viral load in patients with end-stage renal disease with HBV infection

78 The association between a detectable HIV viral load and non-communicable diseases comorbidity in HIV positive adults on antiretroviral therapy in Western Cape, South Africa

79 The kaposi’s sarcoma-associated herpesvirus protein orf42 is required for efficient virion production and expression of viral proteins

80 Disseminated HIV-Associated Kaposi’s Sarcoma With High CD4 Cell Count And Low Viral Load

81 Elements of viral cartography

82 Antioxidants in patients with dengue viral infection.

83 The viral load monitoring cascade in a resource-limited setting: A prospective multicentre cohort study after introduction of routine viral load monitoring in rural Lesotho.

84 Scanometric Detection of Tomato Leaf Curl New Delhi Viral DNA Using Mono- and Bifunctional AuNP-Conjugated Oligonucleotide Probes.

85 Plasma levels of soluble membrane attack complex are elevated despite viral suppression in HIV patients with poor immune reconstitution.

86 The impact of schistosomiasis co-infection in the presentation of viral hepatitis B in migrants: An observational study in non-endemic area.

87 Benign acute viral myositis in African migrants: A clinical, serological and pathological study.

88 Glycan-immobilized dual-channel field effect transistor biosensor for the rapid identification of pandemic influenza viral particles

89 Stable distinct core eukaryotic viromes in different mosquito species from Guadeloupe, using single mosquito viral metagenomics.

90 Respiratory viral infections and the risk of rheumatoid arthritis.

91 Drama Goes Viral: Effects of Story Development on Shares and Views of Online Advertising Videos

92 Aptamers: Novel Molecules as Diagnostic Markers in Bacterial and Viral Infections?

93 Broad-Spectrum Antiviral Activity of an Ankyrin Repeat Protein on Viral Assembly against Chimeric NL4-3 Viruses Carrying Gag/PR Derived from Circulating Strains among Northern Thai Patients

94 The Coat Protein of Citrus Yellow Vein Clearing Virus Interacts with Viral Movement Proteins and Serves as an RNA Silencing Suppressor.

95 Consultation on establishing robust integrated national reporting systems for viral hepatitis

96 Expansion of Viral Load Testing and the Potential Impact on Human Immunodeficiency Virus Drug Resistance.

97 Type-Specific Viral Load and Physical State of HPV Type 16, 18, and 58 as Diagnostic Biomarkers for High-Grade Squamous Intraepithelial Lesions or Cervical Cancer.

98 Structural mass spectrometry goes viral.

99 "Moving Fourth": A Vision Toward Achieving Healthy Living with HIV Beyond Viral Suppression.

100 Murine Cytomegalovirus Protein pM91 Interacts with pM79 and Is Critical for Viral Late Gene Expression.

101 Insights into the functional characteristics of geminivirus rolling-circle replication initiator protein and its interaction with host factors affecting viral DNA replication

Keyword Connections

Journals

Research Groups

Bibliographies